Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/99328
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.creatorLai, WFen_US
dc.creatorZhang, Den_US
dc.creatorWong, WTen_US
dc.date.accessioned2023-07-05T08:37:49Z-
dc.date.available2023-07-05T08:37:49Z-
dc.identifier.issn0167-7799en_US
dc.identifier.urihttp://hdl.handle.net/10397/99328-
dc.language.isoenen_US
dc.publisherElsevier Scienceen_US
dc.rights© 2022 Elsevier Ltd. All rights reserved.en_US
dc.rights© 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.en_US
dc.rightsThe following publication Lai, W.-F., Zhang, D., & Wong, W.-T. (2023). Design of erythrocyte-derived carriers for bioimaging applications. Trends in Biotechnology, 41(2), 228-241 is available at https://dx.doi.org/10.1016/j.tibtech.2022.07.010.en_US
dc.subjectBiodistributionen_US
dc.subjectBlood retentionen_US
dc.subjectCarriersen_US
dc.subjectDiagnosisen_US
dc.subjectErythrocytesen_US
dc.subjectImagingen_US
dc.subjectSurface functionalisationen_US
dc.titleDesign of erythrocyte-derived carriers for bioimaging applicationsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage228en_US
dc.identifier.epage241en_US
dc.identifier.volume41en_US
dc.identifier.issue2en_US
dc.identifier.doi10.1016/j.tibtech.2022.07.010en_US
dcterms.abstractErythrocytes are physiological entities that have been exploited in both preclinical and clinical trials for the delivery of exogenous agents. Over the years, diverse erythrocyte-derived carriers (ECs) have been developed with related patents granted for industrial and commercial purposes. However, most ECs have only been exploited for drug delivery. Serious discussions regarding their applications in imaging are scarce. This article reviews the role of ECs in enhancing imaging efficiency and subsequently delineates strategies for engineering and optimising their preclinical and clinical performance. With a snapshot of the latest developments and use of ECs in imaging, directions to streamline the clinical translation of related technologies can be attained for future research.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationTrends in biotechnology, Feb. 2023, v. 41, no. 2, p. 228-241en_US
dcterms.isPartOfTrends in biotechnologyen_US
dcterms.issued2023-02-
dc.identifier.scopus2-s2.0-85147044922-
dc.identifier.pmid36031485-
dc.identifier.eissn1879-3096en_US
dc.description.validate202307 bcwwen_US
dc.description.oaAccepted Manuscripten_US
dc.identifier.FolderNumbera2215-
dc.identifier.SubFormID47052-
dc.description.fundingSourceSelf-fundeden_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Lai_Design_Erythrocyte-derived_Carriers.pdfPre-Published version1.46 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Final Accepted Manuscript
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

89
Last Week
1
Last month
Citations as of Nov 30, 2025

Downloads

115
Citations as of Nov 30, 2025

SCOPUSTM   
Citations

1
Citations as of Aug 22, 2025

WEB OF SCIENCETM
Citations

1
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.